论文部分内容阅读
目的探讨安阳地区血液制剂容量控制中标示量的范围,为临床输血工作提供可靠的数据支持。方法根据《全血及成分血质量要求GB18469-2001》中容量标准要求结合安阳地区血液制剂制备实际情况,确定出符合安阳地区血液制剂容量标准的标示量范围,并将确定出的标示量范围与实际制备的血液制剂容量进行比对。结果安阳地区来源于400 ml全血的去白全血容量标示范围确定为(460±46)ml;来源于400 ml全血的2 U去白悬浮红细胞容量标示范围确定为(300±30)ml;来源于200 ml全血的1 U去白悬浮红细胞容量标示范围确定为(150±15)ml。安阳地区实际制备的血液制剂容量85%以上都在确定的标示量范围内。结论安阳地区血液制剂容量符合国家标准要求,建议在血液制剂标签上注明标示量范围,血液制剂标示量范围的准确标定具有重要的临床意义。
Objective To explore the range of labeled amount in blood product volume control in Anyang area and provide reliable data support for clinical blood transfusion. Methods According to the requirements of the volumetric standard of GB18469-2001 for whole blood and blood components of blood, combined with the preparation of blood preparations in Anyang area, the range of labeled amount of blood preparations in Anyang area was determined and the range of labeled amount The actual preparation of blood product volume is compared. Results The range of deionized blood volume from 400 ml whole blood in Anyang area was (460 ± 46) ml. The volume of 2 U de-leucocyte suspension from 400 ml whole blood was marked as (300 ± 30) ml ; And the range of labeling capacity of 1 U desubstitized white blood cells derived from 200 ml whole blood was (150 ± 15) ml. Anyang more than 85% of the actual preparation of blood preparations in the identified amount within the range. Conclusion The volume of blood products in Anyang area conforms to the requirements of national standards. It is suggested that the labeled amount should be indicated on the label of blood preparations and the accurate calibration of the range of labeled amount of blood preparations has important clinical significance.